Hepatic hemangiomas: Evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium

American Journal of Roentgenology

Volumn 196, Issue 4, 2011, Pages 824-830

  Tamada, Tsutomu ^a   Ito, Katsuyoshi ^a   Yamamoto, Akira ^a   Sone, Teruki ^a   Kanki, Akihiko ^a   Tanaka, Fuyuki ^a   Higashi, Hiroki ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Contrast enhancement; Gadoxetate disodium; Hemangioma; Liver; MRI

Indexed keywords

GADOXETIC ACID; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM ETHOXYBENZYL DTPA; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HEPATOBILIARY RADIOGRAPHY; HUMAN; IMAGE ANALYSIS; LIVER HEMANGIOMA; LIVER PARENCHYMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SIGNAL NOISE RATIO; ANALYSIS OF VARIANCE; HEMANGIOMA; IMAGE QUALITY; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ANALYSIS OF VARIANCE; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HEMANGIOMA; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHANTOMS, IMAGING; RETROSPECTIVE STUDIES;

EID: 79957868449     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.5113     Document Type: Article

References (24)

1. Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am 1975; 59:995-1013
2. Brannigan M, Burns PN, Wilson SR. Blood flow patterns in focal liver lesions at microbubble-enhanced US. RadioGraphics 2004; 24:921-935 (Pubitemid 38943326)
3. Nelson RC, Chezmar JL. Diagnostic approach to hepatic hemangiomas. Radiology 1990; 176:11-13 (Pubitemid 20208098)
4. Quinn SF, Benjamin GG. Hepatic cavernous hemangiomas: simple diagnostic sign with dynamic bolus CT. Radiology 1992; 182:545-548
5. Leslie DF, Johnson CD, MacCarty RL, Ward EM, Ilstrup DM, Harmsen WS. Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases. AJR 1995; 165:1403-1406
6. Semelka RC, Brown ED, Ascher SM, et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 1994; 192:401-406
7. Hanafusa K, Ohashi I, Himeno Y, Suzuki S, Shibuya H. Hepatic hemangioma: findings with two-phase CT. Radiology 1995; 196:465-469
8. Vilgrain V, Boulos L, Vullierme MP, Denys A, Terris B, Menu Y. Imaging of atypical hemangiomas of the liver with pathologic correlation. RadioGraphics 2000; 20:379-397
9. Semelka RC, Sofka CM. Hepatic hemangiomas. Magn Reson Imaging Clin N Am 1997; 5:241-253 (Pubitemid 27214856)
10. Vogl TJ, Kümmel S, Hammerstingl R, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996; 200:59-67 (Pubitemid 26197732)
11. Hammerstingl R, Huppertz A, Breuer J, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 2008; 18:457-467 (Pubitemid 351248177)
12. Ichikawa T, Saito K, Yoshioka N, et al. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Invest Radiol 2010; 45:133-141
13. Reimer P, Rummeny EJ, Daldrup HE, et al. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 1997; 7:275-280 (Pubitemid 127538595)
14. Halavaara J, Breuer J, Ayuso C, et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT - a multicenter trial. J Comput Assist Tomogr 2006; 30:345-354 (Pubitemid 43922248)
15. Bluemke DA, Sahani D, Amendola M, et al. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 2005; 237:89-98 (Pubitemid 41346150)
16. Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT - initial observations. Radiology 2005; 234:468-478 (Pubitemid 40139918)
17. Huppertz A, Balzer T, Blakeborough A, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acidenhanced MR images with intraoperative findings. Radiology 2004; 230:266-275 (Pubitemid 37549812)
18. Tamada T, Ito K, Sone T, et al. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging 2009; 29:636-640
19. Doo KW, Lee CH, Choi JW, Lee J, Kim KA, Park CM. "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor. AJR 2009; 193:1582; [web]W490-W496
20. Kim T, Federle MP, Baron RL, Peterson MS, Kawamori Y. Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology 2001; 219:699-706 (Pubitemid 32476260)
21. Sasaki K, Ito K, Koike S, Fujita T, Okazaki H, Matsunaga N. Differentiation between hepatic cyst and hemangioma: additive value of breath-hold, multisection fluid-attenuated inversion-recovery magnetic resonance imaging using half-Fourier acquisition single-shot turbo-spin-echo sequence. J Magn Reson Imaging 2005; 21:29-36 (Pubitemid 40041417)
22. Byun JH, Kim TK, Lee CW, et al. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT. Radiology 2004; 232:354-360 (Pubitemid 38971271)
23. Brody JM, Schafer L, Tung GA, Breuer J, Shamsi K. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid. J Magn Reson Imaging 2005; 21:391-397 (Pubitemid 40446434)
24. Reimer P, Schneider G, Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 2004; 14:559-578 (Pubitemid 38444568)